重组人IL6／2融合蛋白对6.5Gy照射小鼠造血功能恢复的影响

观察了ｈＦＰＩＬ６／２对６．５Ｇｙγ线照射ＮＩＨ小鼠第１０天造血功能恢复的影响。结果表明：照射小鼠连续４ｄ给予ｈＦＰＩＬ６／２２５０μｇ·ｋｇ－１·ｄ－１,其脾重、ＣＦＵ－８、骨髓有核细胞数及ＣＭ－ＣＦＵ分别比对照组增加５９．０％、２７８．５％、５７．９％和１３８．２％,统计学处理均有显著差异;对此四项指标的改善也明显优于２５μｇ组。另外,２５０μｇ剂量组小鼠外周血象３０ｄ的动态观察结果表明,ｈＦＰＩＬ６／２不但能明显提高红细胞和血红蛋白的最低值,而且能使血小板的恢复提前。提示ｈＦＰＩＬ６／２在促进血小板生成和促进红系造血方面可能具有良好的应用前景。     

GM－CSF和IL－3对脐带血CD34~＋细胞植入骨髓基质的促进作用

利用抗ＣＤ３４单克隆抗体吸附磁性微球的方法分离纯化脐带血ＣＤ３４＋细胞，将其种入照射后的成年骨髓基质。比较ｒｈＧＭ－ＣＳＦ、ＩＬ－３及两者的联合对植入效率的促进作用。结果表明：经２ｈ铺展贴壁后，对照组只有３６％的ＣＤ３４＋细胞植入基质，而生长因子预处理组则有６８—８９．６％的ＣＤ３４＋细胞植入基质。在长期液体培养体系中则显示了植入ＣＤ３４＋细胞多的处理组造血重建快速而持久。表明ＧＭ－ＣＳＦ和ＩＬ－３预处理将明显提高脐带血移植效率。     

佛波酯对SMMC-7721人肝癌细胞粘附及整合蛋白基因表达的调控作用

用促癌剂佛波酯（ＰＭＡ）作用于ＳＭＭＣ－７７２１人肝癌细胞,研究细胞表面的主要粘附分子α５β１整合蛋白基因表达及相应细胞粘附行为的改变．用１００ｎｍｏｌ／ＬＰＭＡ作用ＳＭＭＣ－７７２１人肝癌细胞,发现其作用因时间的长短而异,作用３０、６０、１２０ｍｉｎ分别增加细胞与纤连蛋白（Ｆｎ）粘附１８．８％、３８．７％和５６．６％,作用６、１２ｈ分别降低４４．０％、３７．４％,而不影响与多聚赖氨酸的粘附．使用足量的抗α５和／或抗β１单抗预先封闭细胞与Ｆｎ的结合点,再将细胞与Ｆｎ粘附,发现α５单抗单独使用可将ＳＭＭＣ－７７２１细胞与Ｆｎ的粘附抑制２０％左右,β１单抗则抑制１４％,两者联合使用时可封闭４０％左右的粘附,提示该细胞表面存在除α５β１外的其它整合蛋白在介导着细胞与Ｆｎ的粘附．进一步应用Ｎｏｒｔｈｅｒｎｂｌｏｔ方法,分析整合蛋白基因表达,发现１００ｎｍｏｌ／ＬＰＭＡ抑制α５亚基转录,以３０ｍｉｎ最明显,抑制达８３．１％,作用６、１２ｈ抑制率仍为４６．６％、４３．６％．还就ＰＭＡ影响细胞粘附和整合蛋白基因表达的可能机理作了讨论．     

小鼠骨髓内皮细胞分泌的细胞因子对造血干/祖细胞增殖的影响

应用小鼠骨髓内皮细胞株细胞传代培养,收集无血清条件培养液（ｍＢＭＥＣ－ＣＭ）,经超滤分成大于１０ｋＤ和小于１０ｋＤ两组分,分别观察两组分的ｍＢＭＥＣ－ＣＭ对小鼠骨髓造血干／祖细胞ＣＦＵ－ＧＭ,ＨＰＰ－ＣＦＣ,ＣＦＵ－Ｅ,ＢＦＵ－Ｅ和ＣＦＵ－Ｍｅｇ的影响。结果表明：含分子量大于１０ｋＤ物质的ｍＢＭＥＣ－ＣＭ的保留液能明显刺激ＣＦＵ－ＧＭ,ＨＰＰ－ＣＦＣ,ＣＦＵ－Ｅ,ＢＦＵ－Ｅ和ＣＦＵ－Ｍｅｇ生长;     

DMSO对人胃腺癌MGC80—3细胞的诱导分化作用

用光镜、电镜和生化分析方法研究ＤＭＳＯ在体外对ＭＧＣ８０－３细胞的作用,不同浓度ＤＭＳＯ对ＭＧＣ８０－３细胞有不同的生长抑制作用。１．５％ＤＭＳＯ是本研究较适合的浓度。１．５％ＤＭＳＯ处理７天后细胞生长率、分裂指数、克隆形成率和Ｃｏｎ－Ａ凝集率分别下降３５．１５％、１８％、９０％和５５．８％。处理后,癌细胞膜的碱性磷酸酶（不存在于正常人胃粘膜）比活性下降了９０％,接种裸鼠致瘤率亦下降７５％。处理后     

低分子量硫酸葡聚糖对小鼠造血干细胞动员作用的研究

给小鼠静脉注射低分子量（＜１０￣４ｕ）硫酸葡聚糖（ＤＳ）１５ｍｇ／ｋｇ后外周血中白细胞、单个核细胞（ｍｏｎｏｎｕｃｌｅａｒｃｅｋ,ＭＮＣ）、ＣＦＵ－ＧＭ、ＢＦＵ－Ｅ和ＣＦＵ－Ｍｉｘ产率等指标出现时相性变化。给药后１ｈ开始升高,２ｈ达到高峰、分别为药前值的２．２、２．６、３．８、４．４和３．０倍,７ｈ时趋向正常。给药后２ｈ上述各类细胞在外周血中的含量随着ＤＳ的剂量增加而增加。白细胞、ＭＮＣ计数在ＤＳ１８０ｍｇ／ｋｇ时达到峰值,均为对照组的４倍。２４０ｍｇ／ｋ８时未见明显增加。不同剂量ＤＳ对各系祖细胞均有不同程度的动员作用,ＤＳ剂量１５－３０ｍｇ／ｋｇ效果最好,每升血中ＣＦＵ－ＧＭ、ＢＦＵ－Ｅ、ＣＦＵ－Ｍｉｘ的数量分别相当于对照组的５．０、１１．９和８．８倍。其峰值出现时间与白细胞、ＭＮＣ不同,表明ＤＳ对不同类型细胞的作用机制也不尽一致。经口给小鼠投以ＤＳ２４０和４８ｏｍｇ／ｋｇ后,未见外周血中白细胞、ＭＮＣ计数有显著性升高,提示对造血干细胞没有动员作用。     

GM—CSF和IL—3对脐带血CD34＋细胞植入骨髓基质的促进作用

利用抗ＣＤ３４单克隆抗体吸附磁性微球的方法分离纯化脐带血ＣＤ３４＾＋细胞,将其种入照射后的成年骨髓基质。比较ｒｈＧＭ－ＣＳＦ、ＩＬ－３及两者的联合对植入效率的促进作用。结果表明：经２ｈ铺展贴壁后,对照组只有３６％的ＣＤ３４＾＋细胞植入基质,而生长因子预处理组则有６８－８９．６％的ＣＤ３４＾＋细胞植入基质。在长期液体培养体系中则显示了植入ＣＤ３４＾＋细胞多的处理组造血重建快速而持久。表明ＧＭ－ＣＳＦ     

可移植性小鼠组织细胞肉瘤侵袭与转移模型的建立

将小鼠可移植性组织细胞肉瘤ＬⅡ分别接种在近交系６１５小鼠的胁部皮下、后肢肌肉和爪垫皮下组织内,取全肺和各部位淋巴结进行组织学检查,观察肿瘤自发转移率及转移程度。胁部皮下与后肢肌肉移植组待荷瘤小鼠自然死亡,平均存活时间分别为３９．３、２７．９ｄ,淋巴结转移率分别为９５．７％和１００％,肺转移率均为１００％。爪垫皮下移植组在肿瘤接种后１、３、５、１０、２０、３０和４０ｄ处死荷瘤小鼠,早期淋巴结转移出现在肿瘤接种后第１０天,至第３０天时形成肺转移瘤。局部侵袭达Ⅲ～Ⅳ级时才发生肿瘤转移,肺转移出现时间晚于淋巴转移。结果表明,ＬⅡ瘤株具有淋巴道合并血道转移的特性,是研究肿瘤侵袭和转移的理想实验肿瘤模型。     

三株散发性戊型肝炎病毒变异株的部分序列比较

对三株散发性戊型肝炎病毒Ｃｈ－Ｔ１１、Ｃｈ－Ｔ２１、Ｃｈ－Ｆ４０的部分基因组做克隆测序,经比较发现与其它国内外ＨＥＶ株ＯＲＦ２部分相应核苷酸序列同源性在７８．３－８１．３,Ｃｈ－Ｔ２１与Ｃｈ－Ｔ４０的核苷酸同源性９８．８％,而Ｃｈ－Ｔ１１与前两者的同源性则分别为８９．８％和９０．２％。Ｃｈ－Ｔ１１、Ｃｈ－Ｔ２１、Ｃｈ－Ｔ４０与其它ＨＥＶ株相应氨基酸序列同源性在９５．８－９７．９％,它们之间的氨基酸     

逆转录病毒载体介导的人多药耐药基因(mdr-1)导入小鼠造血细胞的实验研究

本文利用逆转录病毒介导的基因转移方法,将人多药耐药基因ｍｄｒ－１导入小鼠造血细胞,并对转基因造血细胞的耐药性及移植特性进行了初步研究。含人ｍｄｒ－１ｃＤＮＡ的重组逆转录病毒载体质粒,经脂质体介导的基因转移方法导入包装细胞ＰＡ３１７,再经秋水仙素筛选。获得产逆转录病毒的包装细胞,其病毒滴度可达１．２×１０５ｃｆｕ／ｍｌ。在含小鼠骨髓贴壁细胞层的长期培养体系中,利用逆转录病毒上清对造血细胞进行转染。通过抗性ＣＦＵ－ＣＭ检测,其基因转移效率可达７．０％。将转基因造血细胞移植经照射预处理的小鼠,可重建受体小鼠造血功能。小鼠造血重建后４个月,其骨髓造血细胞与外周血细胞可检测到人ｍｄｒ－１ｃＤＮＡ,且骨髓造血细胞对秋水仙素仍保留抗性     

脑脊液中转移性腺癌细胞免疫表型的变化

目的探讨脑脊液中转移腺癌细胞在没有血供的条件下的生长特征,是否有血管内皮标记物CD34,CD105,FⅧ,淋巴管内皮标记物D2_40及碱性成纤维生长因子(b-FGF)的表达,并促进肺癌的脑转移及肿瘤细胞自我生存的调控。方法采集109例腺癌脑转移患者的脑脊液为研究对象,其中肺癌脑转移107例(包括49例肺癌术后5年内脑转移,58例无肺癌病史直接经脑脊液穿刺发现肺癌脑转移),乳腺癌2例。以40例主要成分为炎性细胞的脑脊液及40例原发性肺腺癌组织标本为对照,采用免疫化学染色方法检测脑转移腺癌细胞及腺癌组织中CD34,CD105,FⅧ,D2_40,b-FGF,VEGF及vimentin的表达。结果 109例脑脊液标本中,CD34,CD105,FⅧ,D2_40,b-FGF及VEGF在转移癌细胞中的阳性率分别为64.2%,67.9%,66.9%,63.8%,56.8%,70.6%明显高于脑脊液对照组(阳性率均为0)且差异具有统计学意义(P0.05)。vimentin在脑脊液转移腺癌细胞中阳性表达,表达率为88.1%。在原发肺癌标本中,CD34,CD105,FⅧ和VEGF表达较弱或不表达。D2-40在癌中不表达。B-FGF与Vimentin在原发肺腺癌中的表达率分别为50.1%和29.3%。结论在肺癌脑转移过程中,肿瘤细胞能够表达不同的血管生长因子,提示可能具备内皮细胞的生物学特性,可能有助于增强肿瘤细胞的转移能力和对环境的耐受能力。     

IRM-2小鼠移植性肿瘤模型的生物学特性

目的观察IRM-2小鼠和C57BL/6小鼠接种Lewis肺癌生物学特性的对比研究。方法取肿瘤组织研磨,用生理盐水稀释成2×10^6/mL,取细胞悬液接种于IRM-2小鼠和C57BL/6小鼠腋下,0.2 mL/只。观察两品系肿瘤生长、荷瘤鼠生存时间,外周血细胞及病理指标变化。结果两品系小鼠成瘤率均是100%,荷瘤鼠存活时间无明显差异,IRM-2小鼠荷瘤鼠体重净增长明显高于C57BL/6荷瘤小鼠（P〈0.05）。白细胞分类及病理指标变化无明显差别。结论IRM-2小鼠与C57BL/6小鼠Lewis肺癌模型生物学特性基本一致,IRM-2小鼠可以建立稳定的Lewis肺癌肿瘤模型应用于实验研究。     

Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2

Tumor-derived exosomes (TEXs) contain enriched miRNAs, and exosomal miRNAs can affect tumor growth, including cell proliferation, metastasis, and drug resistance through cell-to-cell communication. We investigated the role of exosomal miR-1260b derived from non-small cell lung cancer (NSCLC) in tumor progression. Exosomal miR-1260b induced angiogenesis by targeting homeodomain-interacting protein kinase-2 (HIPK2) in human umbilical vein endothelial cells (HUVECs). Furthermore, exosomal miR-1260b or suppression of HIPK2 led to enhanced cellular mobility and cisplatin resistance in NSCLC cells. In patients with NSCLC, the level of HIPK2 was significantly lower in tumor tissues than in normal lung tissues, while that of miR-1260b was higher in tumor tissues. HIPK2 and miR-1260b expression showed an inverse correlation, and this correlation was strong in distant metastasis. Finally, the expression level of exosomal miR-1260b in plasma was higher in patients with NSCLC than in healthy individuals, and higher levels of exosomal miR-1260b were associated with high-grade disease, metastasis, and poor survival. In conclusion, exosomal miR-1260b can promote angiogenesis in HUVECs and metastasis of NSCLC by regulating HIPK2 and may serve as a prognostic marker for lung cancers.Subject terms: Non-small-cell lung cancer, Metastasis, miRNAs     

高转移鼠源性淋巴瘤细胞模型的建立及其生物学特性的研究

该文建立了高转移性小鼠淋巴癌细胞模型,并对其进行了生物学特性研究.LC1和LC2两个细胞系来自同一个小鼠淋巴瘤.通过细胞形态学观察,用常规的细胞生长曲线检测法、染色体核型分析、体外成球实验、侵袭和转移实验及体内成瘤实验检测细胞系的生物学特性及体内外致瘤能力.LC1细胞生长速度低于LC2细胞,LC1细胞的群体倍增时间为(...     

Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model

Proteolytic degradation of the extracellular matrix (ECM) is an important process during tumor invasion. Matrix Metalloproteinase 1 (MMP-1) is one of the proteases that degrade collagen type I, a major component of bone ECM. In the present study, the biological relevance of MMP-1 in osteosarcoma (OS) tumor growth and metastasis was investigated in vitro and in vivo. Human OS cells in primary culture expressed MMP-1 encoding mRNA at considerably higher levels than normal human bone cells. In addition, MMP-1 mRNA and protein expression in the highly metastatic human osteosarcoma 143-B cell line was remarkably higher than in the non-metastatic parental HOS cell line. Stable shRNA-mediated downregulation of MMP-1 in 143-B cells impaired adhesion to collagen I and anchorage-independent growth, reflected by a reduced ability to grow in soft agar. Upon intratibial injection into SCID mice, 143-B cells with shRNA-downregulated MMP-1 expression formed smaller primary tumors and significantly lower numbers of lung micro- and macrometastases than control cells. Conversely, HOS cells stably overexpressing MMP-1 showed an enhanced adhesion capability to collagen I and accelerated anchorage-independent growth compared to empty vector-transduced control cells. Furthermore, and most importantly, individual MMP-1 overexpression in HOS cells enabled the formation of osteolytic primary tumors and lung metastasis while the HOS control cells did not develop any tumors or metastases after intratibial injection. The findings of the present study reveal an important role of MMP-1 in OS primary tumor and metastasis formation to the lung, the major organ of OS metastasis.     

The effects and mechanisms of SLC34A2 in tumorigenesis and progression of human non-small cell lung cancer

Background

SLC34A2 with highest expressions in lung, small intestine and kidney encoded a type 2b sodium-dependent phosphate transporter (NaPi-IIb). In lung, SLC34A2 only expressed in the apical membrane of type II alveolar epithelium cells (ATII cells) and played a pivotal role during the fetal lung development and embryonic development. ATII cells acting as multifunctional stem cells might transform into NSCLC after undergoing exogenous or endogenous factors. Increasing evidences showed that the genes performing critical roles during embryogenesis were also expressed during the development of cancer. In addition, recent research found the expression of SLC34A2 had a significant difference between the surgical samples of NSCLC and normal tissues, and SLC34A2 was down-regulated in lung adenocarcinoma cell line A549 and up-regulation expression of SLC34A2 could significantly inhibit cell viability and invasion of A549 in vitro. These results suggested SLC34A2 might play an important role in the development of NSCLC. However, the role of SLC34A2 in tumorigenesis and progression of NSCLC remains unknown.

Results

Our study found that SLC34A2 was also significantly down-regulated in 14/15 of examined NSCLC tissues. Moreover, we found that expressions of SLC34A2 were reduced in six NSCLC cell lines for the first time. Our result also revealed a dramatic inhibitory effects of SLC34A2 on cell growth, migration and invasion of several NSCLC cell lines. SLC34A2 also strongly inhibited tumor growth and metastasis ability in A549 subcutaneous tumor model and lung metastasis model, respectively. Further studies found that the suppressive effects of SLC34A2 on tumorigenesis and progression might be associated with the down-regulation of related protein in PI3K/Akt and Ras/Raf/MEK signal pathway.

Conclusions

For the first time, our data indicated that SLC34A2 could exert significantly suppressive effects on tumorigenesis and progression of NSCLC. SLC34A2 might provide new insights for further understanding the early pathogenesis of human NSCLC.     

In vitro characteristics of metastatic variant subclones of restricted genetic origin

We have studied several metastatic variant cell lines derived from a common clonal origin and their transformed and untransformed parental cell lines. A number of in vitro characteristics were examined for each tumor line and these properties were correlated with the ability of the tumor cells to form pulmonary nodules in an experimental metastasis assay. Direct correlations with metastatic behavior in the lung colony assay were found to exist with the amount of cell-bound Concanavalin A and the procoagulant activities of cell lysates. In vitro parameters that did not correlate with the metastatic phenotype were: population doubling times in culture, saturation density achieved in culture, the number of colony-forming cells shed from confluent cultures, rates of cellular attachment to homotypic or heterotypic cell monolayers, plasminogen-activator production and procoagulant activity produced in serum-free conditioned medium.     

Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro

As a specific guanine nucleotide exchange factor of Rac 1, Tiam 1 (T-lymphoma invasion and metastasis inducing protein 1) is involved in a number of cellular events, such as cytoskeleton reorganization, cell adhesion, and cell migration. Since Tiaml was implicated in the invasion and metastasis of T-lymphoma cells and breast tumor cells, we compared the expression level of Tiaml in two human giant-cell lung carcinoma cell strains with high or low metastasis potential, and found that Tiaml expression level in high-metastatic 95D cells was higher than that in low-metastatic 95C cells. To further confirm the role of Tiam I in invasion and metastasis, we constructed the antisense Tiaml expression plasmid (pcDNA3-anti-Tiaml), which was transfected into 95D cells. A stable transfected clone with decreased Tiaml expression was screened and selected for further research. Transwell assay showed that down-regulation of endogenous Tiam1 by anti-Tiam1 can reduce the in vitro invasiveness of 95D cells. Our results suggested that Tiam1 signaling contributed to the invasion and metastasis of the human giant-cell lung carcinoma cells.     

Antisense Tiam1 Down-Regulates the Invasiveness of 95D Cells in Vitro

Invasion and metastasis are the main death causes oftumor patients, and aberrant expression of some genescontributes to tumor cell invasion and metastasis [1]. Tiam1was firstly identified as a gene amplified by insertedretrovirus which can confer metastat…